Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

China Vitamin Supplements Market

ID: MRFR/FnB/46654-HCR
128 Pages
Garvit Vyas
Last Updated: April 06, 2026

China Vitamin Supplements Market Size, Share, Industry Trend & Analysis Research Report By Type (Vitamin B, Vitamin C, Vitamin D, Multivitamins, others), By Form (Tablets, Capsules & Soft Gels, Powder, Others) and By Distribution Channel (Store-Based, Non-Store-Based) - Forecast to 2035.

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

China Vitamin Supplements Market Infographic
Purchase Options
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
  2.   1.1 EXECUTIVE SUMMARY
  3.     1.1.1 Market Overview
  4.     1.1.2 Key Findings
  5.     1.1.3 Market Segmentation
  6.     1.1.4 Competitive Landscape
  7.     1.1.5 Challenges and Opportunities
  8.     1.1.6 Future Outlook
  9. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
  10.   2.1 MARKET INTRODUCTION
  11.     2.1.1 Definition
  12.     2.1.2 Scope of the study
  13.       2.1.2.1 Research Objective
  14.       2.1.2.2 Assumption
  15.       2.1.2.3 Limitations
  16.   2.2 RESEARCH METHODOLOGY
  17.     2.2.1 Overview
  18.     2.2.2 Data Mining
  19.     2.2.3 Secondary Research
  20.     2.2.4 Primary Research
  21.       2.2.4.1 Primary Interviews and Information Gathering Process
  22.       2.2.4.2 Breakdown of Primary Respondents
  23.     2.2.5 Forecasting Model
  24.     2.2.6 Market Size Estimation
  25.       2.2.6.1 Bottom-Up Approach
  26.       2.2.6.2 Top-Down Approach
  27.     2.2.7 Data Triangulation
  28.     2.2.8 Validation
  29. 3 SECTION III: QUALITATIVE ANALYSIS
  30.   3.1 MARKET DYNAMICS
  31.     3.1.1 Overview
  32.     3.1.2 Drivers
  33.     3.1.3 Restraints
  34.     3.1.4 Opportunities
  35.   3.2 MARKET FACTOR ANALYSIS
  36.     3.2.1 Value chain Analysis
  37.     3.2.2 Porter's Five Forces Analysis
  38.       3.2.2.1 Bargaining Power of Suppliers
  39.       3.2.2.2 Bargaining Power of Buyers
  40.       3.2.2.3 Threat of New Entrants
  41.       3.2.2.4 Threat of Substitutes
  42.       3.2.2.5 Intensity of Rivalry
  43.     3.2.3 COVID-19 Impact Analysis
  44.       3.2.3.1 Market Impact Analysis
  45.       3.2.3.2 Regional Impact
  46.       3.2.3.3 Opportunity and Threat Analysis
  47. 4 SECTION IV: QUANTITATIVE ANALYSIS
  48.   4.1 Chemicals and Materials, BY Type (USD Billion)
  49.     4.1.1 Multivitamins
  50.     4.1.2 Single Vitamins
  51.     4.1.3 Vitamin Blends
  52.     4.1.4 Vitamin Gummies
  53.   4.2 Chemicals and Materials, BY Formulation (USD Billion)
  54.     4.2.1 Tablets
  55.     4.2.2 Capsules
  56.     4.2.3 Powder
  57.     4.2.4 Liquid
  58.   4.3 Chemicals and Materials, BY Distribution Channel (USD Billion)
  59.     4.3.1 Online Retail
  60.     4.3.2 Pharmacies
  61.     4.3.3 Supermarkets
  62.     4.3.4 Health Stores
  63.   4.4 Chemicals and Materials, BY End User (USD Billion)
  64.     4.4.1 Children
  65.     4.4.2 Adults
  66.     4.4.3 Pregnant Women
  67.     4.4.4 Elderly
  68. 5 SECTION V: COMPETITIVE ANALYSIS
  69.   5.1 Competitive Landscape
  70.     5.1.1 Overview
  71.     5.1.2 Competitive Analysis
  72.     5.1.3 Market share Analysis
  73.     5.1.4 Major Growth Strategy in the Chemicals and Materials
  74.     5.1.5 Competitive Benchmarking
  75.     5.1.6 Leading Players in Terms of Number of Developments in the Chemicals and Materials
  76.     5.1.7 Key developments and growth strategies
  77.       5.1.7.1 New Product Launch/Service Deployment
  78.       5.1.7.2 Merger & Acquisitions
  79.       5.1.7.3 Joint Ventures
  80.     5.1.8 Major Players Financial Matrix
  81.       5.1.8.1 Sales and Operating Income
  82.       5.1.8.2 Major Players R&D Expenditure. 2023
  83.   5.2 Company Profiles
  84.     5.2.1 Herbalife (US)
  85.       5.2.1.1 Financial Overview
  86.       5.2.1.2 Products Offered
  87.       5.2.1.3 Key Developments
  88.       5.2.1.4 SWOT Analysis
  89.       5.2.1.5 Key Strategies
  90.     5.2.2 Amway (US)
  91.       5.2.2.1 Financial Overview
  92.       5.2.2.2 Products Offered
  93.       5.2.2.3 Key Developments
  94.       5.2.2.4 SWOT Analysis
  95.       5.2.2.5 Key Strategies
  96.     5.2.3 GNC Holdings (US)
  97.       5.2.3.1 Financial Overview
  98.       5.2.3.2 Products Offered
  99.       5.2.3.3 Key Developments
  100.       5.2.3.4 SWOT Analysis
  101.       5.2.3.5 Key Strategies
  102.     5.2.4 Nature's Bounty (US)
  103.       5.2.4.1 Financial Overview
  104.       5.2.4.2 Products Offered
  105.       5.2.4.3 Key Developments
  106.       5.2.4.4 SWOT Analysis
  107.       5.2.4.5 Key Strategies
  108.     5.2.5 NOW Foods (US)
  109.       5.2.5.1 Financial Overview
  110.       5.2.5.2 Products Offered
  111.       5.2.5.3 Key Developments
  112.       5.2.5.4 SWOT Analysis
  113.       5.2.5.5 Key Strategies
  114.     5.2.6 Garden of Life (US)
  115.       5.2.6.1 Financial Overview
  116.       5.2.6.2 Products Offered
  117.       5.2.6.3 Key Developments
  118.       5.2.6.4 SWOT Analysis
  119.       5.2.6.5 Key Strategies
  120.     5.2.7 Solgar (US)
  121.       5.2.7.1 Financial Overview
  122.       5.2.7.2 Products Offered
  123.       5.2.7.3 Key Developments
  124.       5.2.7.4 SWOT Analysis
  125.       5.2.7.5 Key Strategies
  126.     5.2.8 Swanson Health Products (US)
  127.       5.2.8.1 Financial Overview
  128.       5.2.8.2 Products Offered
  129.       5.2.8.3 Key Developments
  130.       5.2.8.4 SWOT Analysis
  131.       5.2.8.5 Key Strategies
  132.   5.3 Appendix
  133.     5.3.1 References
  134.     5.3.2 Related Reports
  135. 6 LIST OF FIGURES
  136.   6.1 MARKET SYNOPSIS
  137.   6.2 CHINA MARKET ANALYSIS BY TYPE
  138.   6.3 CHINA MARKET ANALYSIS BY FORMULATION
  139.   6.4 CHINA MARKET ANALYSIS BY DISTRIBUTION CHANNEL
  140.   6.5 CHINA MARKET ANALYSIS BY END USER
  141.   6.6 KEY BUYING CRITERIA OF CHEMICALS AND MATERIALS
  142.   6.7 RESEARCH PROCESS OF MRFR
  143.   6.8 DRO ANALYSIS OF CHEMICALS AND MATERIALS
  144.   6.9 DRIVERS IMPACT ANALYSIS: CHEMICALS AND MATERIALS
  145.   6.10 RESTRAINTS IMPACT ANALYSIS: CHEMICALS AND MATERIALS
  146.   6.11 SUPPLY / VALUE CHAIN: CHEMICALS AND MATERIALS
  147.   6.12 CHEMICALS AND MATERIALS, BY TYPE, 2024 (% SHARE)
  148.   6.13 CHEMICALS AND MATERIALS, BY TYPE, 2024 TO 2035 (USD Billion)
  149.   6.14 CHEMICALS AND MATERIALS, BY FORMULATION, 2024 (% SHARE)
  150.   6.15 CHEMICALS AND MATERIALS, BY FORMULATION, 2024 TO 2035 (USD Billion)
  151.   6.16 CHEMICALS AND MATERIALS, BY DISTRIBUTION CHANNEL, 2024 (% SHARE)
  152.   6.17 CHEMICALS AND MATERIALS, BY DISTRIBUTION CHANNEL, 2024 TO 2035 (USD Billion)
  153.   6.18 CHEMICALS AND MATERIALS, BY END USER, 2024 (% SHARE)
  154.   6.19 CHEMICALS AND MATERIALS, BY END USER, 2024 TO 2035 (USD Billion)
  155.   6.20 BENCHMARKING OF MAJOR COMPETITORS
  156. 7 LIST OF TABLES
  157.   7.1 LIST OF ASSUMPTIONS
  158.     7.1.1
  159.   7.2 China MARKET SIZE ESTIMATES; FORECAST
  160.     7.2.1 BY TYPE, 2025-2035 (USD Billion)
  161.     7.2.2 BY FORMULATION, 2025-2035 (USD Billion)
  162.     7.2.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  163.     7.2.4 BY END USER, 2025-2035 (USD Billion)
  164.   7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  165.     7.3.1
  166.   7.4 ACQUISITION/PARTNERSHIP
  167.     7.4.1

China Chemicals and Materials Market Segmentation

Chemicals and Materials By Type (USD Billion, 2025-2035)

  • Multivitamins
  • Single Vitamins
  • Vitamin Blends
  • Vitamin Gummies

Chemicals and Materials By Formulation (USD Billion, 2025-2035)

  • Tablets
  • Capsules
  • Powder
  • Liquid

Chemicals and Materials By Distribution Channel (USD Billion, 2025-2035)

  • Online Retail
  • Pharmacies
  • Supermarkets
  • Health Stores

Chemicals and Materials By End User (USD Billion, 2025-2035)

  • Children
  • Adults
  • Pregnant Women
  • Elderly

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions